Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study.
Yiying YangXiaoan KeLian DuanHongbo YangFeng Ying GongHui PanLinjie WangHui-Juan ZhuPublished in: The Journal of clinical endocrinology and metabolism (2024)
Pediatric prolactinomas exihibited more severe clinical characteristics in boys and in patients diagnosed during earlier stages of pubertal developments. Given the overall efficacy of PRL normalization by medication and considerable surgical remission rate in noninvasive tumors, DAs remain first-line recommendation for prolactinomas in children and adolescents, while surgery might be viable for noninvasive tumors.
Keyphrases
- end stage renal disease
- disease activity
- chronic kidney disease
- newly diagnosed
- minimally invasive
- ejection fraction
- healthcare
- prognostic factors
- coronary artery bypass
- systemic lupus erythematosus
- type diabetes
- rheumatoid arthritis
- patient reported outcomes
- metabolic syndrome
- acute coronary syndrome
- drug induced